Fortress Biotech
FBIO
84 hedge funds and large institutions have $107M invested in Fortress Biotech in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 29 reducing their positions, and 13 closing their positions.
96% more call options, than puts
Call options by funds: $1.16M | Put options by funds: $595K
0.17% less ownership
Funds ownership: 2.23% → 2.06% (-0.17%)
3% less capital invested
Capital invested by funds: $110M → $107M (-$3.27M)
7% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 29
8% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 13
1% less funds holding
Funds holding: 85 → 84 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$950K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$922K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$576K |
| 4 |
State Street
Boston,
Massachusetts
|
+$569K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$329K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.32M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.69M |
| 3 |
BlackRock
New York
|
-$761K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$451K |
| 5 |
Two Sigma Advisers
New York
|
-$421K |
FBIO Hedge Fund Activity: Q2 2021 in Review
84 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2021, worth a combined $107M — down 3% from $110M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of FBIO and 12 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 27 added.
The largest buyer was Morgan Stanley, adding an estimated $950K. The largest seller was Nantahala Capital Management, cutting an estimated $4.32M.
- 84 institutional investors held Fortress Biotech (FBIO) as of Q2 2021, down from 85 in Q1 2021.
- Funds reported $107M of Fortress Biotech stock for Q2 2021, down 3% quarter-over-quarter.
- 12 funds opened new Fortress Biotech positions in Q2 2021 and 13 closed out, a net change of -1 holder.
- The largest Fortress Biotech buyer in Q2 2021 was Morgan Stanley, an estimated $950K added.
- The largest Fortress Biotech seller in Q2 2021 was Nantahala Capital Management, an estimated $4.32M sold.
Based on aggregated 13F filings for Q2 2021.